Skip to main content
. 2017 Apr 7;23(13):2385–2395. doi: 10.3748/wjg.v23.i13.2385

Table 3.

Comparison between bone marrow standardized uptake value and BM-to-liver uptake ratio according to tumor factors

BM SUV P value BLR P value
Pathology PAC/TAC 1.49 ± 0.34 0.143 0.73 ± 0.17 0.081
PDAC 1.54 ± 0.37 0.75 ± 0.16
SRC/MAC 1.41 ± 0.32 0.68 ± 0.16
T stage T1 1.46 ± 0.35 0.042 0.71 ± 0.16 0.003
T2-T4 1.54 ± 0.33 0.78 ± 0.17
Lymph node metastasis Absence 1.47 ± 0.34 0.123 0.72 ± 0.16 0.010
Presence 1.54 ± 0.36 0.77 ± 0.17
FDG uptake Negative 1.46 ± 0.30 0.007 0.71 ± 0.14 0.006
Positive 1.52 ± 0.38 0.75 ± 0.18
Recurrence No 1.47 ± 0.34 0.001 0.72 ± 0.16 <0.001
Yes 1.68 ± 0.36 0.85 ± 0.16

BM: Bone marrow; BLR: BM-to-liver uptake ratio; PAC: Papillary adenocarcinoma; TAC: Tubular adenocarcinoma; PDAC: Poorly-differentiated adenocarcinoma; SRC: Signet-ring cell carcinoma; MAC: Mucinous adenocarcinoma; FDG: F-18 fluorodexoyglucose.